Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digoxin plus chemotherapy in adult lymphoid malignancies
ChiCTR-ONRC-13003369Phase 2Recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Sep 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of digoxin in Acute Leukaemia, diffuse large B-cell lymphoma (DLBCL) and lymphoma (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoints: overall survival and disease-free survival. Started Sep 2013; status: recruiting.
02
Drugs
digoxin
03
Conditions
Acute Leukaemiadiffuse large B-cell lymphoma (DLBCL)lymphoma
Beyond the preview
Go deeper on ChiCTR-ONRC-13003369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-13003369.